BDBM50093253 (+)-3'-Methylspiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidin-2'-one]::(-)-3'-Methylspiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidin-2'-one]::3'-Methylspiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidin-2'-one]::CHEMBL129932

SMILES CN1CC2(CN3CCC2CC3)OC1=O

InChI Key InChIKey=PCLJPJDFFBIZIP-UHFFFAOYSA-N

Data  6 KI  1 Kd  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 9 hits for monomerid = 50093253   

TargetNeuronal acetylcholine receptor subunit alpha-7(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50093253((+)-3'-Methylspiro[1-azabicyclo[2.2.2]octane-3,5'-...)
Affinity DataKi:  250nMAssay Description:binding affinity in rat hippocampi against alpha7 nicotinic receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuronal acetylcholine receptor subunit alpha-7(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50093253((+)-3'-Methylspiro[1-azabicyclo[2.2.2]octane-3,5'-...)
Affinity DataKi:  250nMAssay Description:binding affinity in rat hippocampi against alpha7 nicotinic receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuronal acetylcholine receptor subunit alpha-4/beta-2(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50093253((+)-3'-Methylspiro[1-azabicyclo[2.2.2]octane-3,5'-...)
Affinity DataKi:  450nMAssay Description:binding affinity in rat forebrain against alpha4-beta2 nicotinic receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuronal acetylcholine receptor subunit alpha-4/beta-2(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50093253((+)-3'-Methylspiro[1-azabicyclo[2.2.2]octane-3,5'-...)
Affinity DataKi:  450nMAssay Description:binding affinity in rat forebrain against alpha4-beta2 nicotinic receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuronal acetylcholine receptor subunit alpha-4/beta-2(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50093253((+)-3'-Methylspiro[1-azabicyclo[2.2.2]octane-3,5'-...)
Affinity DataKi:  2.40E+4nMAssay Description:binding affinity in rat forebrain against alpha4-beta2 nicotinic receptor; value range is 1000.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuronal acetylcholine receptor subunit alpha-7(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50093253((+)-3'-Methylspiro[1-azabicyclo[2.2.2]octane-3,5'-...)
Affinity DataKi: >3.20E+4nMAssay Description:binding affinity in rat hippocampi against alpha7 nicotinic receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
University Of Kentucky

Curated by ChEMBL
LigandPNGBDBM50093253((+)-3'-Methylspiro[1-azabicyclo[2.2.2]octane-3,5'-...)
Affinity DataKd:  220nMAssay Description:Displacement of [125I]alpha-bungarotoxin from alpha7 nAChRMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuronal acetylcholine receptor subunit alpha-7(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50093253((+)-3'-Methylspiro[1-azabicyclo[2.2.2]octane-3,5'-...)
Affinity DataEC50:  6.00E+6nMAssay Description:Potency was determined by measuring current activation in Xenopus oocytes expressing rat alpha7 nAChRsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuronal acetylcholine receptor subunit alpha-7(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50093253((+)-3'-Methylspiro[1-azabicyclo[2.2.2]octane-3,5'-...)
Affinity DataEC50:  6.00E+6nMAssay Description:Potency was determined by measuring current activation in Xenopus oocytes expressing rat alpha7 nAChRsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed